Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04907578

Thromboelastography (TEG) In the Intrauterine Growth Restriction (IUGR) Neonatal Population by Gestational Age

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

The investigators aim to improve the understanding of TEG in this population in an effort to improve outcomes in a population at high risk in both the presence and absence of blood product transfusions.

Detailed description

The investigators plan to 1.) examine dynamic hemostasis as measured by TEG in the intrauterine growth restriction (IUGR) neonatal population due to a high risk of requiring blood transfusions, 2.) determine the influence of gestational age on TEG in this population, and 3.) examine the utility of TEG as a tool for identifying coagulopathy in IUGR neonates. The investigators hypothesize that thromboelastography parameters will change with gestational age in the IUGR population in a manner similar to non-IUGR populations and that neonatal comorbidities, maternal factors, and socioeconomic status will influence TEG values; TEG is likely a useful marker of dynamic hemostasis in this neonatal subpopulation.

Conditions

Timeline

Start date
2021-08-12
Primary completion
2021-08-12
Completion
2021-08-12
First posted
2021-05-28
Last updated
2021-08-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04907578. Inclusion in this directory is not an endorsement.

Thromboelastography (TEG) In the Intrauterine Growth Restriction (IUGR) Neonatal Population by Gestational Age (NCT04907578) · Clinical Trials Directory